| 000 | 01013 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517110925.0 | ||
| 264 | 0 | _c20180123 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1463-1326 | ||
| 024 | 7 |
_a10.1111/dom.12756 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRussell-Jones, D L | |
| 245 | 0 | 0 |
_aHepato-preferential insulins: Is this the end, or the end of the beginning? _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _c11 2016 |
||
| 300 |
_a1053-1054 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aInsulin Lispro _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 18 _gno. 11 _gp. 1053-1054 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/dom.12756 _zAvailable from publisher's website |
| 999 |
_c26297711 _d26297711 |
||